Delirium
Delirium
)
Dr sadia yasir
DSM-5 Criteria
Synonyms and terminology
Prevalence
Recognition
Risk Factors
Clinical features
Pathophysiology
A CASE PRESENTATION
Etiology
Assessment
Treatment
Prevention
Further Specifiers
– Time
Acute : Hours/Days
Persistent: Weeks/Months
– Level of activity
Hyperactive
Hypoactive
Mixed level of activity
Severe burn
Nursing home
Post CABG
Post op patients
AIDS
ICU elderly
Hospitalzed cancer
Hospitalized elderly
ER
0 10 20 30 40 50 60 70 80 90
• Increased Mortality
– Almost 25% more chances of death with delirium in hospitalized patients (Curyto et. al, 2007)
– Adjusted risk of death – twice as compared to non-delirious controls (Inouye et. al, 1998)
• Increased Morbidity
– Poor functional recovery
– Possible future cognitive decline
– Increased risk of complications
– Increased nursing home placement
– Increased costs and LOS
– Depression, PTSD
• Temporal course
– Abrupt or acute onset
• Within days
– Fluctuation in symptom severity
• Waxing and waning
• Worse at night
• May result in diagnostic uncertainty
• Thought disturbances
– Disorganized
• Language disturbances
– Word finding problems
– Dysgraphia
– Dysarthria
– Dysnomia
• Perceptual disturbances
– Misperceptions
– Hallucinations (Visual >> Auditory)
Academy of Consultation-Liaison Psychiatry
Clinical Features
• Psychomotor abnormalities
– Hyper, hypo or mixed
• Sleep-wake cycle disturbance
– Insomnia
– Frequent napping or drowsiness during the day
– Reversal of sleep/wake cycle
• Delusions
– Usually paranoid and not systematized
• Affective lability
• Neurologic abnormalities
Academy of Consultation-Liaison Psychiatry
Differential Diagnosis of Delirium
Delirium Dementia Depression
Onset Abrupt Slow and insidious Variable
16
Pathophysiology of Delirium: Acetylcholine
• Acetylcholine
– The cholinergic system is involved in:
• Attention
• Arousal
• Memory
– Decreased cholinergic activity produces deficits in:
• Information processing
• Arousal
• Attention and ability to focus
– Various metabolic insults, thiamine deficiency and anti-cholinergic medications all can produce
delirium through a decrease in cholinergic activity
• Dopamine
– An excess of dopamine may be a source of the agitation, delusions and psychosis
in delirious patients
– There is an inverse relationship between dopamine and acetylcholine levels
– Dopaminergic agents may induce delirium
– Dopamine antagonists are an effective treatment for delirium
• Recognition
• Consider screening tool for ancillary staff (e.g. brief cognitive assessment)
• History
– Establish course of mental status changes
• Talk to family or caregivers
• Recent medication change(s)
• Symptoms of medical illness
• Review medical record
• Review anesthesia record if post-op
– Onset of delirium is best clue to causality
• Non-pharmacologic Interventions
– Aims
• Cognitively non-demanding
• Limit the risk of harm to self and/or others
– Types
• Avoid interruption of sleep
• Room close to nursing station
• Sitter, feeding assistance and encouragement during meals
• Clocks and calendar and orientation board
• Adequate lighting
• Sensory aids, cleaning of ear wax
Devlin, JW et al. “Impact of Quetiapine on resolution of individual delirium symptoms in critically ill patients with
delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study”. Critical Care; vol. 15(5):
R215; September 17, 2011.
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association,
Washington, D.C., 2013.
Drake, Robert E, Caton, Carol, et al. “A Prospective 2-Year Study of Emergency Department Patients with Early-
Phase Primary Psychosis or Substance-Induced Psychosis”. American Journal of Psychiatry 168:7; pp.742-748, July
2011.
European Delirium Association, American Delirium Society (2014). The DSM-5 criteria, level of arousal and
delirium diagnosis: inclusiveness is safer. BMC medicine, 12, 141. doi:10.1186/s12916-014-0141-2
Flaherty, J. H., et al. (2017). "Dissecting Delirium: Phenotypes, Consequences, Screening, Diagnosis, Prevention,
Treatment, and Program Implementation." Clin Geriatr Med 33(3): 393-413.
Flurie, R. W., et al. (2015). "Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive
care unit to discharge." Am J Health Syst Pharm 72(23 Suppl 3): S133-139.
Fong, T. G., Tulebaev, S. R., Inouye, S. K., (2011). Delirium in elderly adults: diagnosis, prevention and treatment.
Nature Review Neurology 5, 210-220. doi: [10.1038/nrneurol.2009.24]
Francis, Joseph. “Prevention and Treatment of Delirium and Confusional States”. Up-to-date 2011.
Grover S, Kumar V, Chakrabarti S. Comparative efficacy study of haloperidol, olanzapine and risperidone in
delirium. J. Psychosom. Res. 2011; 71: 277–281.
Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics
2004; 45: 297–301.
Han J, Wilson A, & Ely E., (2013). Delirium in the Older Emergency Department Patient – A Quiet Epidemic. Emerg
Med Clin North Am. doi: [10.1016/j.emc.2010.03.005]
Hshieh, T. T., et al. (2015). "Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-
analysis." JAMA Intern Med 175(4): 512-520
Inouye SK, Rushing JT, Foreman MD, et al: Does delirium contribute to poor hospital outcome? J Gen Intern Med
13:234-242, 1998.
Inouye, S., van Dyck, C., Alessi, C., Balkin, S., Siegal, A., Horwitz, R., (1990). Clarifying confusion: The confusion
assessment method. Annuals of Internal Medicine, 113(12), 941-948.
Kalish, V. B., et al. (2014). "Delirium in older persons: evaluation and management." Am Fam Physician 90(3): 150-
158.
Khan, B. A., et al. (2015). "Update on Pharmacotherapy for Prevention and Treatment of Post-operative Delirium:
A Systematic Evidence Review." Curr Anesthesiol Rep 5(1): 57-64.
Kim, S., et al. (2017). "Delirium characteristics and outcomes in medical and surgical lnpatients: A subgroup
analysis." J Crit Care 43: 156-162.
Kooi, W. A., Zaal, I., Klijn, F., Koek, L. K., Meijer, C. R., Leijten, F., Slooter, A., (2015). Delirium Detection Using EEG.
Chest 1 (147) 94-101.
Lewis LM, Miller DK, Morley JE, et al: Unrecognized delirium in ED geriatric patients. Am J Emerg Med. 13(2):142-
5, 1995.
McCusker, J., Cole, M., Dendukuri, N., Han, Ling., Belzile., (2003). The Course of Delirium in Older Medical
Inpatients. A prospective study. Journal of General Internal Medicine 18(9) 696-704. doi: [
10.1046/j.1525-1497.2003.20602.x]
Morandi, A., Pandharipande, P., Trabucchi, M. et al. Intensive Care Med (2008) 34: 1907.
https://doi.org/10.1007/s00134-008-1177-6
Oldham, M. A., et al. (2017). "Responding to Ten Common Delirium Misconceptions With Best Evidence: An
Educational Review for Clinicians." J Neuropsychiatry Clin Neurosci: appineuropsych17030065
Miller, Marcia O. “Evaluation and Management of Delirium in Hospitalized Older Patients”. American Family
Physician, vol. 78, no. 11; pp. 1265-1270, December 1, 2008.
Remington, Gary and Kapur, Shitij. “Antipsychotic Dosing: How Much but also How Often?”. Schizophrenia
Bulletin, vol. 36 no. 5 pp. 900-903, July 21, 2010.
Rockwell K, Cosway S, Stolee P, et al: Increasing the recognition of delirium in elderly patients. J Am Geriatr Soc.
42(3):252-6, 1994.
Tahir TA, Eeles E, Karapareddy V et al. A randomized controlled trial of quetiapine versus placebo in the treatment
of delirium. J. Psychosom. Res. 2010; 69: 485–490.
Taylor, John B, et al: Delirium. In Massachusetts, General Hospital: Psychiatry Update and Board Preparation.
MGH Psychiatry Academy Publishing, 2012.
The Cochran Collaboration. “Antipsychotics for Delirium”. Published by John Wiley & Sons, Ltd. Issue 1, 2009.
Sandeep, Grover et al. “Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium”.
Journal of Psychosomatic Research; vol. 71, issue 4, pp. 277-281, October 2011.
Serafim, R. B., et al. (2015). "Pharmacologic prevention and treatment of delirium in intensive care patients: A
systematic review." J Crit Care 30(4): 799-807.
Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: Treating delirium in a critical care
setting. Intensive Care Med. 2004; 30: 444–449.
Soiza, R., Sharma, V., Ferguson, K., Shenkin S., Seymour, D., MacLullich, A., (2008). Neuroimaging studies of
delirium: A systemic review. Journal of Psychosomatic Research 65(3) 239-248.
Stahl, S. M: Essential Psychopharmacology, 4th Ed. Cambridge University Press, 2016
Virtual Mentor. 2008. Differentiating among Depression, Delirium, and Dementia in Elderly Patients. 10(6):383-
388. doi: 10.1001/virtualmentor.2008.10.6.cprl1-0806
Wang, Phillip et al. “Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications”. New
England Journal of Medicine; 353; pp. 2335-2341; December 2005.
Wong, Camilla, et al. “Does This Patient Have Delirium? Value of Bedside Instruments”. Journal of the American
Medical Association, vol. 304, no. &; pp 779-785; August 18, 2010.
Academy of Consultation-Liaison Psychiatry 37